CLINICAL_TRIALS trial_result · 2022-12-14

Clinical Trial Update: A 6-Month Extension Study of OTO-104 in Meniere's Disease [Phase 3]

A phase 3 extension study of OTO-104 in Meniere's Disease was terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Otonomy, Inc. | Conditions: Meniere's Disease | Phase 3 | Status: TERMINATED | Results posted: 2022-12-14